Reaction Details Report a problem with these data
Target
Uracil nucleotide/cysteinyl leukotriene receptor
Ligand
BDBM646550
Substrate
n/a
Meas. Tech.
GPR17 cAMP Assay Protocol
IC50
17.0±n/a nM
Citation
GALLEY, G; GOBBI, L; GUBA, W; MAZUNIN, D; PINARD, E; RICCI, A PYRIMIDIN-2-YL SULFONAMIDE DERIVATIVES US Patent US20240025883 Publication Date 1/25/2024
More Info.:
Target
Name:
Uracil nucleotide/cysteinyl leukotriene receptor
Synonyms:
GPR17 | GPR17_HUMAN
Type:
PROTEIN
Mol. Mass.:
41013.71
Organism:
Homo sapiens (Human)
Description:
ChEMBL_1353471
Residue:
367
Sequence:
MSKRSWWAGSRKPPREMLKLSGSDSSQSMNGLEVAPPGLITNFSLATAEQCGQETPLENMLFASFYLLDFILALVGNTLALWLFIRDHKSGTPANVFLMHLAVADLSCVLVLPTRLVYHFSGNHWPFGEIACRLTGFLFYLNMYASIYFLTCISADRFLAIVHPVKSLKLRRPLYAHLACAFLWVVVAVAMAPLLVSPQTVQTNHTVVCLQLYREKASHHALVSLAVAFTFPFITTVTCYLLIIRSLRQGLRVEKRLKTKAVRMIAIVLAIFLVCFVPYHVNRSVYVLHYRSHGASCATQRILALANRITSCLTSLNGALDPIMYFFVAEKFRHALCNLLCGKRLKGPPPSFEGKTNESSLSAKSEL
Inhibitor
Name:
BDBM646550
Synonyms:
6-chloro-N-[4,6-dimethoxy-5- (1,1,2- trifluoroethoxy)pyrimidin-2- yl]-1H-indole-3-sulfonamide | US20240025883, Example 55
Type:
Small organic molecule
Emp. Form.:
C16H14ClF3N4O5S
Mol. Mass.:
466.819
SMILES:
COc1nc(NS(=O)(=O)c2c[nH]c3cc(Cl)ccc23)nc(OC)c1OC(F)(F)CF